ATE250340T1 - 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele - Google Patents

7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele

Info

Publication number: ATE250340T1
Authority: AT; Austria
Prior art keywords: paclitaxele; methylthiooxomethyl; methylthiodioxomethyl; present; invention concerns
Prior art date: 1997-02-28

Application number

AT98908734T

Other languages

English (en)

Inventor

Jerzy Golik

Dolatrai M Vyas

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-02-28

Filing date

1998-02-24

Publication date

2003-10-15

1998-02-24 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

2003-10-15 Application granted granted Critical

2003-10-15 Publication of ATE250340T1 publication Critical patent/ATE250340T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Epoxy Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT98908734T 1997-02-28 1998-02-24 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele ATE250340T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3948097P	1997-02-28	1997-02-28
PCT/US1998/003741 WO1998037765A1 (en)	1997-02-28	1998-02-24	7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels

Publications (1)

Publication Number	Publication Date
ATE250340T1 true ATE250340T1 (de)	2003-10-15

Family

ID=21905699

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98908734T ATE250340T1 (de)	1997-02-28	1998-02-24	7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele

Country Status (11)

Country	Link
US (1)	US5902822A (de)
EP (1)	EP1011329B1 (de)
JP (1)	JP2001513778A (de)
AT (1)	ATE250340T1 (de)
AU (1)	AU724591B2 (de)
CA (1)	CA2282264A1 (de)
DE (1)	DE69818492T2 (de)
DK (1)	DK1011329T3 (de)
ES (1)	ES2207817T3 (de)
PT (1)	PT1011329E (de)
WO (1)	WO1998037765A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999046904A1 (en) *	1998-03-12	1999-09-16	John Griffits	Improved realtime internet functions by use of a hybrid pstn and ip protocol means
WO2001024763A2 (en)	1999-10-01	2001-04-12	Immunogen, Inc.	Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AU7007001A (en)	2000-06-22	2002-01-02	Nitromed Inc	Nitrosated and nitrosylated taxanes, compositions and methods of use
PL217731B1 (pl)	2006-06-01	2014-08-29	Tomasz Byrski	Sposób wykrywania genetycznie uwarunkowanej obniżonej odpowiedzi na chemioterapię cytostatykiem taksanowym, zastosowanie mutacji założycielskiej oraz zestawu do wykrywania takiej odpowiedzi
EP3007692A1 (de)	2013-06-11	2016-04-20	Bayer Pharma Aktiengesellschaft	Kombinationen zur behandlung von krebs mit einem mps-1-kinaseinhibitor und einem mitotischen inhibitor

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2601675B1 (fr) *	1986-07-17	1988-09-23	Rhone Poulenc Sante	Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4960790A (en) *	1989-03-09	1990-10-02	University Of Kansas	Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
EP0642503B1 (de) *	1991-09-23	1999-12-01	Florida State University	10-disacetoxytaxolderivate
US5272171A (en) *	1992-02-13	1993-12-21	Bristol-Myers Squibb Company	Phosphonooxy and carbonate derivatives of taxol
DE69325454T2 (de) *	1992-04-17	2000-01-20	Abbott Laboratories, Abbott Park	Taxol-derivate
US5254580A (en) *	1993-01-19	1993-10-19	Bristol-Myers Squibb Company	7,8-cyclopropataxanes
US5294637A (en) *	1992-07-01	1994-03-15	Bristol-Myers Squibb Company	Fluoro taxols
CA2100808A1 (en) *	1992-10-01	1994-04-02	Vittorio Farina	Deoxy paclitaxels
FR2697019B1 (fr) *	1992-10-15	1994-11-25	Rhone Poulenc Rorer Sa	Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
CA2109861C (en) *	1992-12-04	1999-03-16	Shu-Hui Chen	6,7-modified paclitaxels
AU679206B2 (en) *	1992-12-23	1997-06-26	Bristol-Myers Squibb Company	Novel sidechain-bearing taxanes and intermediates thereof
US5646176A (en) *	1992-12-24	1997-07-08	Bristol-Myers Squibb Company	Phosphonooxymethyl ethers of taxane derivatives
CA2111527C (en) *	1992-12-24	2000-07-18	Jerzy Golik	Phosphonooxymethyl ethers of taxane derivatives
EP0687260B1 (de) *	1993-03-05	2003-02-19	Florida State University	Verfahren zur Herstellung von 9-Desoxotaxanen
US5703247A (en) *	1993-03-11	1997-12-30	Virginia Tech Intellectual Properties, Inc.	2-Debenzoyl-2-acyl taxol derivatives and methods for making same
IL127598A (en) *	1994-01-28	2003-04-10	Upjohn Co	Process for preparing isotaxol analogs
CA2192373A1 (en) *	1994-06-09	1995-12-14	Hirofumi Terasawa	Deacetoxytaxol derivative
WO1996000724A1 (en) *	1994-06-28	1996-01-11	Pharmacia & Upjohn Company	7-ether-taxol analogs, antineoplastic use and pharmaceutical compositions containing them
CN1073105C (zh) *	1994-07-26	2001-10-17	因迪纳有限公司	具有抗肿瘤活性的半合成紫杉烷
US6201140B1 (en) *	1994-07-28	2001-03-13	Bristol-Myers Squibb Company	7-0-ethers of taxane derivatives

1998
- 1998-02-18 US US09/025,270 patent/US5902822A/en not_active Expired - Fee Related
- 1998-02-24 ES ES98908734T patent/ES2207817T3/es not_active Expired - Lifetime
- 1998-02-24 DE DE69818492T patent/DE69818492T2/de not_active Expired - Fee Related
- 1998-02-24 EP EP98908734A patent/EP1011329B1/de not_active Expired - Lifetime
- 1998-02-24 PT PT98908734T patent/PT1011329E/pt unknown
- 1998-02-24 JP JP53783998A patent/JP2001513778A/ja not_active Ceased
- 1998-02-24 AU AU66686/98A patent/AU724591B2/en not_active Ceased
- 1998-02-24 CA CA002282264A patent/CA2282264A1/en not_active Abandoned
- 1998-02-24 AT AT98908734T patent/ATE250340T1/de not_active IP Right Cessation
- 1998-02-24 DK DK98908734T patent/DK1011329T3/da active
- 1998-02-24 WO PCT/US1998/003741 patent/WO1998037765A1/en not_active Ceased

Also Published As

Publication number	Publication date
AU724591B2 (en)	2000-09-28
EP1011329A1 (de)	2000-06-28
US5902822A (en)	1999-05-11
AU6668698A (en)	1998-09-18
ES2207817T3 (es)	2004-06-01
DK1011329T3 (da)	2003-12-22
DE69818492D1 (en)	2003-10-30
EP1011329A4 (de)	2000-07-26
EP1011329B1 (de)	2003-09-24
CA2282264A1 (en)	1998-09-03
PT1011329E (pt)	2004-01-30
WO1998037765A1 (en)	1998-09-03
DE69818492T2 (de)	2004-07-22
JP2001513778A (ja)	2001-09-04

Publication	Publication Date	Title
ES2184149T3 (es)	2003-04-01	Paclitaxeles 6-tio sustituidos.
DK0971717T3 (da)	2002-03-25	Cytotoksiske aminosukker- og relaterede sukkerderivater af indolopyrrolocarbazoler
CY1108610T1 (el)	2014-04-09	Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE231872T1 (de)	2003-02-15	Thiazolopyrimidinderivate
FI943749A0 (fi)	1994-08-15	Taksaanijohdannaisten fosfono-oksimetyylieetterit
ID23374A (id)	2000-04-20	Halogenopirimidin
TR199901077A3 (tr)	1999-12-21	Ispençiyari formülasyonlar.
TR199800436A3 (tr)	1998-10-21	Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
ES2181744T3 (es)	2003-03-01	Hidratos de paclitaxel cristalinos.
MX9601994A (es)	1997-08-30	Profarmacos de derivados de paclitaxel.
SE9904377D0 (sv)	1999-12-01	Pharmaceutical combinations
SE9802937D0 (sv)	1998-09-01	Novel compounds
ATE250340T1 (de)	2003-10-15	7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele
AU4558201A (en)	2001-10-03	Taxane anticancer agents
MA26604A1 (fr)	2004-12-20	Compositions pharmaceutiques.
NO20021429L (no)	2002-05-27	1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
ITSV20010001U4 (it)	1999-09-06	Vedi invenzione n. 16 del 1998

Legal Events

Date	Code	Title	Description
2004-07-15	UEP	Publication of translation of european patent specification	Ref document number: 1011329 Country of ref document: EP
2006-11-15	REN	Ceased due to non-payment of the annual fee

Date

Code

Title

Description

2004-07-15

UEP

Publication of translation of european patent specification

Ref document number: 1011329

Country of ref document: EP

2006-11-15

REN

Ceased due to non-payment of the annual fee